Bacillus anthracis Peptidoglycan Integrity Is Disrupted by the Chemokine CXCL10 through the FtsE/X Complex

Frontiers in Microbiology
Katie R MargulieuxMolly A Hughes

Abstract

The antimicrobial activity of the chemokine CXCL10 against vegetative cells of Bacillus anthracis occurs via both bacterial FtsE/X-dependent and-independent pathways. Previous studies established that the FtsE/X-dependent pathway was mediated through interaction of the N-terminal region(s) of CXCL10 with a functional FtsE/X complex, while the FtsE/X-independent pathway was mediated through the C-terminal α-helix of CXCL10. Both pathways result in cell lysis and death of B. anthracis. In other bacterial species, it has been shown that FtsE/X is involved in cellular elongation though activation of complex-associated peptidoglycan hydrolases. Thus, we hypothesized that the CXCL10-mediated killing of vegetative cells of B. anthracis through the FtsE/X-dependent pathway resulted from the disruption of peptidoglycan processing. Immunofluorescence microscopy studies using fluorescent peptidoglycan probes revealed that incubation of B. anthracis Sterne (parent) strain with CXCL10 or a C-terminal truncated CXCL10 (CTTC) affected peptidoglycan processing and/or incorporation of precursors into the cell wall. B. anthracis ΔftsX or ftsE(K123A/D481N) mutant strains, which lacked a functional FtsE/X complex, exhibited little to no evidence o...Continue Reading

References

Jul 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·E M Wise, J T Park
Oct 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·D J Tipper, J L Strominger
Feb 27, 1999·Molecular Microbiology·E de LeeuwJ Luirink
May 20, 2000·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·S BernatchezJ A Dillon
Jun 3, 2000·Annual Review of Immunology·D Rossi, A Zlotnik
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·I Chopra, M Roberts
Jul 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A M ColeR M Strieter
Sep 7, 2001·Annual Review of Microbiology·M Mock, A Fouet
Aug 14, 2002·Biochemistry·Valerie BoothBrian D Sykes
Jan 16, 2003·The Journal of Biological Chemistry·Stephen E GirardinPhilippe J Sansonetti
May 10, 2003·Structure·G Jawahar SwaminathanK Ravi Acharya
Jul 23, 2003·The Journal of Biological Chemistry·Stephen E GirardinDominique Mengin-Lecreulx
Sep 2, 2003·Journal of Leukocyte Biology·De YangJoost J Oppenheim
Oct 31, 2003·Expert Reviews in Molecular Medicine·M J Frederick, G L Clayman
Jan 20, 2004·Journal of Bacteriology·Kari L SchmidtDavid S Weiss
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Jan 18, 2006·Archives of Microbiology·Mushtaq Ahmad MirParthasarathi Ajitkumar
Aug 19, 2007·Nature Reviews. Microbiology·Michael R Yeaman, Nannette Y Yount
Jun 25, 2008·Molecular Microbiology·Sharon Garti-LeviSigal Ben-Yehuda
Apr 21, 2009·Journal of Bacteriology·S J Ryan ArendsDavid S Weiss
Jan 12, 2010·Trends in Microbiology·Waldemar Vollmer, Stephen J Seligman
May 5, 2010·Nature Reviews. Microbiology·Michael A KohanskiJames J Collins
Jan 15, 2011·Trends in Biotechnology·Timothy D H BuggDavid I Roper
Jul 29, 2011·Applied Microbiology and Biotechnology·Jan Reith, Christoph Mayer
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Matthew A CrawfordMolly A Hughes
Dec 29, 2011·Nature Reviews. Microbiology·Athanasios TypasWaldemar Vollmer
May 29, 2012·Immunity·Albert Zlotnik, Osamu Yoshie
Jun 6, 2012·Annual Review of Biochemistry·Andrew L LoveringNatalie C J Strynadka
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Sep 14, 2012·Frontiers in Immunology·Sunny C Yung, Philip M Murphy
Oct 17, 2012·Molecular Microbiology·Waldemar Vollmer
Jan 8, 2013·Frontiers in Immunology·Leonard T Nguyen, Hans J Vogel
Jul 23, 2013·Molecular Microbiology·Patricia Domínguez-CuevasJeff Errington
Aug 6, 2013·Current Opinion in Structural Biology·Solmaz SobhanifarNatalie C J Strynadka
Dec 18, 2013·Nature Reviews. Immunology·Dana J PhilpottStephen E Girardin
Jan 11, 2014·Molecular Microbiology·Robert D TurnerSimon J Foster
May 9, 2014·Nature Communications·Sergio G BartualJuan A Hermoso
May 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Daniela MavriciTom Alber

❮ Previous
Next ❯

Methods Mentioned

BETA
confocal microscopy
light microscopy

Software Mentioned

Image J
GraphPad Prism

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.